+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison of nucleotide sequences of the a ann arbor 6 60 live attenuated influenza vaccine donor strain and its wild type parent



Comparison of nucleotide sequences of the a ann arbor 6 60 live attenuated influenza vaccine donor strain and its wild type parent



Ginsberg, H , Et Al (Ed ) Vaccines (Cold Spring Harbor), 88 New Chemical And Genetic Approaches to Vaccination: Prevention Of Aids And Other Viral, Bacterial And Parasitic Diseases; Conference, Cold Spring Harbor, New York, Usa, September 9, 1987 Xxiii+396p Cold Spring Harbor Laboratory: Cold Spring Harbor, New York, Usa Illus Paper 139-144




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 027975882

Download citation: RISBibTeXText


Related references

Onset of immunity with Mycoplasma synoviae: comparison of the live attenuated vaccine MS-H (Vaxsafe MS) with its wild-type parent strain (86079/7NS). Avian Diseases 50(1): 82-87, 2006

Duration of immunity with Mycoplasma synoviae: comparison of the live attenuated vaccine MS-H (Vaxsafe MS) with its wild-type parent strain, 86079/7NS. Avian Diseases 50(2): 228-231, 2006

Comparison of the entire nucleotide and deduced amino acid sequences of the attenuated hog cholera vaccine strain GPE- and the wild-type parental strain ALD. Archives of Virology 140(8): 1385-1391, 1995

Quadrivalent Ann Arbor strain live-attenuated influenza vaccine. Expert Review of Vaccines 11(11): 1293-1303, 2012

Comparison of the nucleotide and deduced amino acid sequences of the envelope protein genes of the wild-type French viscerotropic strain of yellow fever virus and the live vaccine strain, French neurotropic vaccine, derived from it. Virology 192(2): 692-695, 1993

Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age. Vaccine 29(26): 4322-4327, 2011

A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age. Vaccine 30(19): 2989-2998, 2012

Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2). Virology 167(2): 554-567, 1988

A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18-49 years of age. Vaccine 30(20): 3053-3060, 2012

A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24-59 months of age. Vaccine 31(14): 1812-1818, 2013

Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference. Expert Review of Vaccines 10(8): 1131-1141, 2011